返回 Agenda
TOPIC 2 SESSION 1 CONTINUED: SUSAR Reporting in Clinical Trials and Case Studies
Session Chair(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert
GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
SUSAR Reporting in Clinical Trials and Case Studies
Gaby L. Danan, MD, PHD
GLD, France
Pharmacovigilance Expert